What is the spectrum of Guillain-Barré syndrome?The clinical spectrum of Guillain-Barré syndrome is varied—at least three different types have been identified. In Europe and North America about 95% of cases are acute inflammatory demyelinating polyradiculoneuropathy and the other 5% are acute axonal motor disorder and acute sensory and motor axonal neuropathy.2 The frequency of these axonal neuropathies varies throughout the world, and in Asia and South America they make up about 30% of the syndrome.3 The closely related Miller Fisher syndrome is thought to be an inflammatory neuropathy that affects the cranial nerves to the eye muscles in particular, and it is characterised by ophthalmoplegia, accompanied by areflexia and ataxia but not weakness.4 Some cases of acute inflammatory demyelinating polyradiculoneuropathy have features of the Miller Fisher syndrome, but with associated weakness.The incidence of Guillain-Barré syndrome varied from 1.2 per 100 000 to 1.6 per 100 000 in the most recent and carefully conducted European studies.5 6 The incidence rises with age but is bimodal in some studies,7 with a minor peak in young adults, and is slightly more common in men.8 Twelve cases of familial Guillain-Barré syndrome have been described,9 10 but there is no strong HLA link,11 although one study suggested a link with a CD1 polymorphism.12 Recurrence of pure Guillain-Barré syndrome is rare, and patients with a more chronic disease that resembles Guillain-Barré syndrome but takes longer than four weeks to reach its nadir are classified as having subacute or chronic inflammatory demyelinating polyneuropathy. These patients behave differently to those with Guillain-Barré syndrome and often respond to steroids.13